Author Correction: A purine scaffold Hsp90 inhibitor destabilizes BCL-6 and has specific antitumor activity in BCL-6-dependent B cell lymphomas. uri icon

Overview

authors

  • Cerchietti, Leandro
  • Lopes, Eloisi C
  • Yang, Shao Ning
  • Hatzi, Katerina
  • Bunting, Karen L
  • Tsikitas, Lucas A
  • Mallik, Alka
  • Robles, Ana I
  • Walling, Jennifer
  • Varticovski, Lyuba
  • Shaknovich, Rita
  • Bhalla, Kapil N
  • Chiosis, Gabriela
  • Melnick, Ari M.

publication date

  • April 3, 2024

Identity

Digital Object Identifier (DOI)

  • 10.1038/s41591-024-02957-0

PubMed ID

  • 38570701